首页> 外国专利> MAGNETOTATIC BACTERIA MRI POSITIVE CONTRACT ENHANCEMENT AGENT AND METHODS OF USE

MAGNETOTATIC BACTERIA MRI POSITIVE CONTRACT ENHANCEMENT AGENT AND METHODS OF USE

机译:磁动细菌MRI阳性对比增强剂和使用方法

摘要

Magnetic resonance imaging (MRI) is enhanced by contrast agents such as superparamagnetic iron-oxide (SPIO) particles that resemble magnetite particles produced by magnetotactic bacteria. Magnetospirillum magneticum AMB-1 produces positive MRI contrast when generating ultrasmall magnetite particles (10-40 nm diameter). Positive MRI contrast permits clearer distinction from image voids compared to negative contrast. T1-weighted MRI showed that such bacteria increased positive contrast 2.2-fold (p0.02) in vitro and 2.0-fold (p0.02) following intratumoral injection in mouse tumor xenografts. Upon intravenous delivery, Magnetospirillum magneticum AMB-1 targeted tumors and generated increased positive MRI contrast in them (1.4-fold; p0.01). AMB-1 tumor targeting was shown by viable counts, microPET imaging of radio-labeled AMB-1, and Prussian blue staining of tumor sections. Thus, magnetotactic bacteria provide a tool for improving cancer diagnosis and monitoring treatment response by MRI.
机译:磁共振成像(MRI)通过造影剂(例如超顺磁性氧化铁(SPIO)颗粒)增强,它们类似于趋磁细菌产生的磁铁矿颗粒。当产生超小的磁铁矿颗粒(直径10-40 nm)时,磁性螺旋藻 AMB-1产生正MRI对比。与负对比相比,正MRI对比可以更清晰地区分图像空隙。 T1加权MRI显示,这种细菌在小鼠肿瘤异种移植物中进行瘤内注射后,其体外阳性对照增加2.2倍(p <0.02),而在肿瘤内注射后增加2.0倍(p <0.02)。静脉内分娩后, Magnetospirillum magneticum AMB-1靶向肿瘤,并在其中产生增强的MRI阳性对照(1.4倍; p <0.01)。通过活计数,放射性标记的AMB-1的microPET成像以及肿瘤切片的普鲁士蓝染色显示了AMB-1肿瘤的靶向性。因此,趋磁细菌提供了用于改善癌症诊断和通过MRI监测治疗反应的工具。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号